Target intelligence / Profile preview

DNA polymerase III PolC-type (PolC)

Target
PolC
Molecular classification
Enzyme, Transferase, DNA-directed DNA polymerase
01

Overview

Bacterial DNA polymerase III (Pol III) from Staphylococcus aureus is the essential enzyme complex responsible for the bulk of chromosomal DNA replication. In Gram-positive bacteria like S. aureus, the replicative machinery is distinct from Gram-negative models because it utilizes two different Pol III enzymes: PolC and DnaE. PolC is the primary replicative polymerase, performing the majority of leading and lagging strand synthesis and possessing intrinsic 3'-5' exonuclease activity for proofreading. DnaE in S. aureus is primarily involved in extending RNA primers before handing off the synthesis to PolC. Because PolC is essential for bacterial survival and lacks a direct human homolog, it serves as a high-priority target for the development of novel antibiotics, particularly against multi-drug resistant strains like MRSA. Drugs targeting this enzyme, such as 6-anilinouracils, typically act by competing with deoxyguanosine triphosphate (dGTP) or by forming a stable, inactive complex with the DNA template, effectively halting the replication fork and inducing bacterial cell death.

Other names
PolCDNA polymerase III alpha subunitReplicative DNA polymerasepolC gene productDPO3_STAA1
02

Mechanism of action

Inhibition of DNA synthesis by competing with dGTP or sequestering the enzyme into an inactive DNA-drug-protein complex, thereby stalling the replication fork and preventing chromosomal duplication.

03

Biological functions

DNA replicationChromosomal duplication3'-5' exonuclease activityProofreadingDNA-directed DNA polymerase activity
04

Disease associations

InfectionStaphylococcal infectionMethicillin-resistant Staphylococcus aureus (MRSA) infection
05

Safety considerations

Selectivity against human DNA polymerasesRapid development of antibiotic resistance through target site mutations (e.g., Ser765 to Leu)Potential for cross-resistance within the 6-anilinouracil class
06

Interacting drugs

6-anilinouracils

4 more in the full profile.

07

Biomarkers

Bacterial DNA synthesis rateBacterial loadPolC gene mutation status

Beyond the preview

Go deeper on DNA polymerase III PolC-type (PolC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase III PolC-type (PolC).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call